[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350088-105":59,"doc-detail-350088-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","s100a4-characterize-antigen-presenting-cancer-associated-fibroblasts-and-predicts-surgical-outcomes-in-relapsed-ovarian-cancer","S100A4 characterize antigen-presenting cancer-associated fibroblasts and predicts surgical outcomes in relapsed ovarian cancer","","Relapsed ovarian cancer poses major therapeutic challenges, and complete resection during secondary cytoreductive surgery (SCR) improves survival, yet the mechanisms through the tumor microenvironment remain unclear. A multi-platform integrative analysis combined spatial, single-cell, and transcriptomic methods to define cancer-associated fibroblast (CAF) heterogeneity and link specific CAF subsets to immune modulation and surgical prognosis. Results highlight S100A4+ CAFs, especially an antigen-presenting S100A4+apCAF subset, associated with R0 outcomes and improved overall survival.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/s100a4-characterize-antigen-presenting-cancer-associated-fibroblasts-and-predicts-surgical-outcomes-in-relapsed-ovarian-cancer/350088/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/s100a4-characterize-antigen-presenting-cancer-associated-fibroblasts-and-predicts-surgical-outcomes-in-relapsed-ovarian-cancer/350088.png","ImageObject",300,407,{"name":92,"@type":93},"WPS_1786070896","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What clinical problem does the study address in relapsed ovarian cancer?","Question",{"text":112,"@type":113},"It addresses the difficulty of predicting who benefits from complete resection during secondary cytoreductive surgery (SCR). The study focuses on how the tumor microenvironment influences surgical outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were CAF subtypes characterized in relapsed ovarian cancer?",{"text":117,"@type":113},"The study used multiplex immunohistochemistry and spatial digital phenotyping on 31 samples, single-cell RNA sequencing on 11 tumors to define CAF clusters, and transcriptomic meta-analysis across external datasets to evaluate prognostic significance.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the significance of S100A4+ and antigen-presenting S100A4+apCAF subsets?",{"text":121,"@type":113},"S100A4+ CAFs were enriched in tumor-adjacent stroma and closely associated with complete tumor resection (R0). A distinct antigen-presenting subset co-expressing CD74 (S100A4+apCAFs) showed enhanced interaction with CD4+ T cells and was enriched in R0 patients, with higher related gene expression linked to improved overall survival.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350088,1790212021,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549768072016,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","S100A4 characterize antigen-presenting cancer-associated fibroblasts and predicts surgical outcomes in relapsed ovarian cancer  \nYilizhati Maimaiti*, Yulian Chen*, Longxia Li*, Meichun Cai, Zeyun Li, Lifeng Lin, Shangbing Gao, Guanglei Zhuang, Wei Wu  \nand Rongyu Zang  \nAbstract  \nBackground: Relapsed ovarian cancer (ROC) presents significant therapeutic challenges, and complete resection during secondary cytoreductive surgery (SCR) has been associated with improved survival. However, the contribution of the tumor microenvironment (TME), particularly cancer-associated fibroblasts (CAFs), to surgical outcomes remains unclear. Objectives: This study aimed to characterize CAFs heterogeneity in ROC and identify specific CAF subsets associated with immune modulation and surgical prognosis.  \nDesign: A multi-platform integrative study combining spatial, single-cell, and transcriptomic analyses to investigate CAF phenotypes and their clinical relevance in ROC.  \nMethods: Multiplex immunohistochemistry and spatial digital phenotyping were performed on 31 ROC samples. Single-cell RNA sequencing (scRNA-seq) was conducted on 11 tumors to define CAF clusters. Transcriptomic meta-analysis across multiple external datasets was used to evaluate prognostic significance. Spatial relationships between CAF subsets and immune cells were analyzed, and antigen-presenting CAF signatures were assessed based on marker co-expression patterns.  \nResults: We identified a predominant S100A4 + CAFs population enriched in the tumoradjacent stroma, characterized by extracellular matrix remodeling and immune-regulatory gene expression. S100A4 + CAFs displayed closer spatial proximity to T cells and were significantly associated with complete tumor resection (R0) outcomes. Furthermore, a distinct antigen-presenting subset co-expressing CD74 (S100A4 +apCAFs) exhibited enhanced interaction with CD4 + T cells and was significantly enriched in R0 patients. Meta-analysis across multiple transcriptomic datasets revealed that high expression of S100A4 +apCAFsrelated genes correlated with improved overall survival (hazard ratio = 0 .81, 95% confidence interval: 0.69–0. 95) .  \nConclusion: This study identifies S100A4 + CAFs—particularly the antigen-presenting S100A4 +apCAF subset—as key components of the ROC microenvironment linked to favorable immune contexture and surgical outcomes. These findings highlight S100A4 +apCAFs as potential prognostic biomarkers and immunomodulatory targets, offering new perspectives for personalized therapeutic strategies in ROC.  \nTherAdv Med Oncol 2026, Vol. 18: 1–15  \nDOI: 10. 1177/ 17588359261436959 © The Author(s), 2026.  \nArticle reuse guidelines: [sagepub.com/journals](sagepub.com/journals)permissions  \nCorrespondence to:  \nWei Wu  \nRongyu Zang  \nDepartment of Gynecologic Oncology, Cancer Center, Institute for Ovarian Cancer, Fudan University Zhongshan Hospital, Fudan University, Shanghai 200032, China  \n[waynewu1122@163.com](waynewu1122@163.com)[ ](waynewu1122@163.com)[zang.rongyu@zs-hospital.](zang.rongyu@zs-hospital.)[ ](zang.rongyu@zs-hospital.)[sh.cn](sh.cn)  \nYilizhati Maimaiti Yulian Chen Longxia Li Zeyun Li  \nLifeng Lin Shangbing Gao  \nDepartment of Gynecologic Oncology, Cancer Center, Institute for Ovarian Cancer, Fudan University Zhongshan Hospital, Fudan University, Shanghai, China  \nMeichun Cai Guanglei Zhuang  \nShanghai Key Laboratory of Gynecologic Oncology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China  \n*These authors contributed equally to this work  \n[journals.sagepub.com/home/tam](journals.sagepub.com/home/tam) 1  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License  \n([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use, reproduction and distribution of the work without further permission  \nprovided t","cbCaieUW7lOzIZyS","https://ap.wps.com/l/cbCaieUW7lOzIZyS","pdf",9526562,15,"English","# Abstract\n## Background and objectives\n## Study design and methods\n## Key results\n## Conclusion\n# Plain language summary\n## Clinical problem and approach\n## Main discoveries\n## Prognostic implications","[{\"question\":\"What clinical problem does the study address in relapsed ovarian cancer?\",\"answer\":\"It addresses the difficulty of predicting who benefits from complete resection during secondary cytoreductive surgery (SCR). The study focuses on how the tumor microenvironment influences surgical outcomes.\"},{\"question\":\"How were CAF subtypes characterized in relapsed ovarian cancer?\",\"answer\":\"The study used multiplex immunohistochemistry and spatial digital phenotyping on 31 samples, single-cell RNA sequencing on 11 tumors to define CAF clusters, and transcriptomic meta-analysis across external datasets to evaluate prognostic significance.\"},{\"question\":\"What is the significance of S100A4+ and antigen-presenting S100A4+apCAF subsets?\",\"answer\":\"S100A4+ CAFs were enriched in tumor-adjacent stroma and closely associated with complete tumor resection (R0). A distinct antigen-presenting subset co-expressing CD74 (S100A4+apCAFs) showed enhanced interaction with CD4+ T cells and was enriched in R0 patients, with higher related gene expression linked to improved overall survival.\"}]","S100A4 characterize antigen-presenting cancer-associated fibroblasts and predicts surgical outcomes in relapsed ovarian cancer | PDF",1790087118,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/629b43da7eff04a3370784d6c0eb684a.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c46d90fac5ebccebaa87e151d061316.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2ecacab27662125f73c71ceb8142fc0.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e2210af2a33ccca673233f682aca981.webp",980,1306]